| Date | Form | Description | Docs | XBRL | Pages |
| 10/14/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 09/14/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
79 | |
| 06/14/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
56 | |
| 03/17/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
52 | |
| 09/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 09/14/10 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 03/17/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
47 | |
| 09/09/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
33 | |
| 06/18/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 |
Latest News & Events
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Read More...Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Read More...